C07D 219/12
Amino-alkylamino radicals attached in position 9
C07D219/12 (Amino-alkylamino radicals attached in position 9) appears on 52 US grants and 38 published applications in this corpus.
Search patents in C07D- Granted patents
- 52
- Published applications
- 38
- Assignees
- 52
- Inventors
- 172
- Latest grant
- 1 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 2 |
| 2002 | 3 | 2 |
| 2003 | 2 | 2 |
| 2004 | 0 | 2 |
| 2005 | 1 | 1 |
| 2006 | 0 | 2 |
| 2007 | 1 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 3 |
| 2014 | 2 | 2 |
| 2015 | 4 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 2 |
| 2018 | 1 | 7 |
| 2019 | 4 | 1 |
| 2020 | 3 | 2 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Bisaminoquinolines and bisaminoacridines compounds and methods of their use1 Jul 2025US 12,343,339 B2The Trustees of the University of Pennsylvania
- Compositions and methods for making donor-acceptor azetines5 Jul 2022US 11,377,420 B2Board of Regents, The University of Texas System
- 1,4-bis(3-aminopropyl)piperazine derivative and its use20 Oct 2020US 10,807,958 B2Inserm (Institut National De La Sante Et De La Recherche Medicale)
- Dimeric quinacrine derivatives as autophagy inhibitors for cancer therapy15 Sep 2020US 10,774,047 B2The Trustees of the University of Pennsylvania
- Autophagy inhibitors28 Jan 2020US 10,544,100 B2The Translational Genomics Research Institute
- Novel ras inhibitors27 Nov 2025US 2025/0360124 A1
- Innate immune-activating drug and use thereof7 Aug 2025US 2025/0248992 A1Luoda Biopharma (Suzhou) Co., Ltd.
- Quinacrine and derivatives thereof for treatment of viral infections28 Nov 2024US 2024/0391876 A1Arizona Board of Regents on Behalf of the University of Arizona
- Bisaminoquinolines and bisaminoacridines compounds and methods of their use4 Aug 2022US 2022/0241267 A1The Trustees of the University of Pennsylvania
- Dimeric Quinacrine Derivatives As Autophagy Inhibitors For Cancer Therapy11 Mar 2021US 2021/0070712 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods234US 5,414,077 AGilead Sciences, Inc. · 1995
- Method for inactivating pathogens in red cell compositions using quinacrine mustard63US 5,691,132 ACerus Corporation · 1997
- Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases61US 6,479,504 B1Georgia State University Research Foundation, Inc. · 2002
- Treating red blood cell solutions with anti-viral agents57US 5,559,250 ASteritech, Inc. · 1996
- Treating blood or blood product with a compound having a mustard and a nucleic acid binding moiety47US 6,171,777 B2Cerus Corporation · 2001